Cognitive impairment epidemiology in elderly with type 2 diabetes mellitus
AbstractAccording to current guidelines screening for cognitive impairment (CI) is necessary in patients with diabetes mellitus type 2 over the age of 65 years. In this cross-sectional study we enrolled 135 patients with average age of 71.5 (68-77) and diabetes duration 13.0 (10-20) years. Recruitment performed between December 2019 and December 2020. All patients were screened with Mini-Mental State Exam and pass wide neuropsychological testing. MMSE showed that 35.6% of patients had mild CI 35.6 and 7.4% had demented state. Additional neuropsychological testing found out wide range of cognitive dysfunction even in patient without CI in MMSE. Keywords: elderly patient, diabetes mellitus type 2, cognitive impairment
Keywords:elderly patient, diabetes mellitus type 2, cognitive impairment
Funding. The study had no sponsor support.
Conflict of interest. The author declares no conflict of interest.
For citation: Balashova A.V., Nikolaev M.D., Fadeev V.V., Glinkina I.V. Cognitive impairment epidemiology in elderly with type 2 diabetes mellitus. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2021; 10 (2): 154-6. DOI: https://doi.org/10.33029/2304-9529-2021-10-2-154-156 (in Russian)
References
1. Geriatrics: National guidelines. In: O.N. Tkacheva, E.V. Frolova, N.N. Yakhno (eds). Moscow: GEOTAR-Media, 2018: 608 p. (in Russian)
2. 12. Older Adults: Standards of Medical Care in Diabetes - 2021 American Diabetes Association. Diabetes Care. 2021; 44 (suppl 1): S 168-79. DOI: https://doi.org/10.2337/dc21-S012
3. LeRoith D., Biessels G.J., Braithwaite S.S., Casanueva F.F., Draznin B., Halter J.B. et al. Treatment of diabetes in older adults: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2019; 104 (5): 1520-74. DOI: https://doi.org/10.1210/jc.2019-00198